|
- 2018
Clinical relevance of the 21-gene Recurrence Score? assay in treatment decisions for patients with node-positive breast cancer in the genomic eraDOI: 10.1038/s41523-018-0082-6 Abstract: Studies included in this analysis of the Recurrence Score assay in node-positive breast cancer (N?=?9055
|